Literature DB >> 30735692

Respiratory depression and brain hypoxia induced by opioid drugs: Morphine, oxycodone, heroin, and fentanyl.

Eugene A Kiyatkin1.   

Abstract

Opioid drugs are important tools to alleviate pain of different origins, but they have strong addictive potential and their abuse at higher doses often results in serious health complications. Respiratory depression that leads to brain hypoxia is perhaps the most dangerous symptom of acute intoxication with opioids, and it could result in lethality. The development of substrate-specific sensors coupled with amperometry made it possible to directly evaluate physiological and drug-induced fluctuations in brain oxygen levels in awake, freely-moving rats. The goal of this review paper is to consider changes in brain oxygen levels induced by several opioid drugs (heroin, fentanyl, oxycodone, morphine). While some of these drugs are widely used in clinical practice, they all are abused, often at doses exceeding the clinical range and often resulting in serious health complications. First, we consider some basic knowledge regarding brain oxygen, its physiological fluctuations, and mechanisms involved in regulating its entry into brain tissue. Then, we present and discuss data on brain oxygen changes induced by each opioid drug within a wide range of doses, from low, behaviorally relevant, to high, likely to be self-administered by drug users. These data allowed us to compare the effects of these drugs on brain oxygen in terms of their potency, time-course, and their potential danger when used at high doses via rapid-onset administration routes. While most data discussed in this work were obtained in rats, we believe that these data have clear human relevance in addressing the alarming rise in lethality associated with the opioid abuse.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Brain hypoxia; Health complications; Metabolic brain activation; Nucleus accumbens; Opiates; Rats

Mesh:

Substances:

Year:  2019        PMID: 30735692      PMCID: PMC6500744          DOI: 10.1016/j.neuropharm.2019.02.008

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  60 in total

1.  Fluctuations in brain glucose concentration during behavioral testing: dissociations between brain areas and between brain and blood.

Authors:  E C McNay; R C McCarty; P E Gold
Journal:  Neurobiol Learn Mem       Date:  2001-05       Impact factor: 2.877

2.  Rapid fluctuations in extracellular brain glucose levels induced by natural arousing stimuli and intravenous cocaine: fueling the brain during neural activation.

Authors:  Eugene A Kiyatkin; Magalie Lenoir
Journal:  J Neurophysiol       Date:  2012-06-20       Impact factor: 2.714

Review 3.  Relationship between Nonmedical Prescription-Opioid Use and Heroin Use.

Authors:  Wilson M Compton; Christopher M Jones; Grant T Baldwin
Journal:  N Engl J Med       Date:  2016-01-14       Impact factor: 91.245

4.  Fentanyl-Induced Brain Hypoxia Triggers Brain Hyperglycemia and Biphasic Changes in Brain Temperature.

Authors:  Ernesto Solis; Keaton T Cameron-Burr; Yavin Shaham; Eugene A Kiyatkin
Journal:  Neuropsychopharmacology       Date:  2017-08-29       Impact factor: 7.853

5.  Rapid changes in extracellular glucose levels and blood flow in the striatum of the freely moving rat.

Authors:  L K Fellows; M G Boutelle
Journal:  Brain Res       Date:  1993-02-26       Impact factor: 3.252

Review 6.  Energetic aspects of nerve conduction: the relationships between heat production, electrical activity and metabolism.

Authors:  J M Ritchie
Journal:  Prog Biophys Mol Biol       Date:  1973       Impact factor: 3.667

7.  Pharmacological profiles of fentanyl analogs at mu, delta and kappa opiate receptors.

Authors:  P Maguire; N Tsai; J Kamal; C Cometta-Morini; C Upton; G Loew
Journal:  Eur J Pharmacol       Date:  1992-03-24       Impact factor: 4.432

8.  Extracellular glucose concentration in mammalian brain: continuous monitoring of changes during increased neuronal activity and upon limitation in oxygen supply in normo-, hypo-, and hyperglycemic animals.

Authors:  I A Silver; M Erecińska
Journal:  J Neurosci       Date:  1994-08       Impact factor: 6.167

9.  Extracellular brain glucose levels reflect local neuronal activity: a microdialysis study in awake, freely moving rats.

Authors:  L K Fellows; M G Boutelle; M Fillenz
Journal:  J Neurochem       Date:  1992-12       Impact factor: 5.372

10.  Opposing mechanisms underlying differential changes in brain oxygen and temperature induced by intravenous morphine.

Authors:  Ernesto Solis; Anum Afzal; Eugene A Kiyatkin
Journal:  J Neurophysiol       Date:  2018-09-05       Impact factor: 2.714

View more
  35 in total

1.  Cocaine added to heroin fails to affect heroin-induced brain hypoxia.

Authors:  Shruthi A Thomas; David Perekopskiy; Eugene A Kiyatkin
Journal:  Brain Res       Date:  2020-07-06       Impact factor: 3.252

Review 2.  Noradrenergic Mechanisms in Fentanyl-Mediated Rapid Death Explain Failure of Naloxone in the Opioid Crisis.

Authors:  Randy Torralva; Aaron Janowsky
Journal:  J Pharmacol Exp Ther       Date:  2019-09-06       Impact factor: 4.030

3.  Confronting the opioid crisis with basic research in neuropharmacology.

Authors:  Michael H Baumann; Gavril W Pasternak; Sidney S Negus
Journal:  Neuropharmacology       Date:  2020-01-17       Impact factor: 5.250

Review 4.  Understanding and countering opioid-induced respiratory depression.

Authors:  Jordan T Bateman; Sandy E Saunders; Erica S Levitt
Journal:  Br J Pharmacol       Date:  2021-06-05       Impact factor: 8.739

5.  Opioid use disorder and health service utilization among COVID-19 patients in the US: A nationwide cohort from the Cerner Real-World Data.

Authors:  Fares Qeadan; Benjamin Tingey; Rona Bern; Christina A Porucznik; Kevin English; Ali I Saeed; Erin Fanning Madden
Journal:  EClinicalMedicine       Date:  2021-06-04

6.  In a Rat Model of Opioid Maintenance, the G Protein-Biased Mu Opioid Receptor Agonist TRV130 Decreases Relapse to Oxycodone Seeking and Taking and Prevents Oxycodone-Induced Brain Hypoxia.

Authors:  Jennifer M Bossert; Eugene A Kiyatkin; Hannah Korah; Jennifer K Hoots; Anum Afzal; David Perekopskiy; Shruthi Thomas; Ida Fredriksson; Bruce E Blough; S Stevens Negus; David H Epstein; Yavin Shaham
Journal:  Biol Psychiatry       Date:  2020-02-24       Impact factor: 13.382

7.  Prescription opioid policies and associations with opioid overdose and related adverse effects.

Authors:  Valerie S Harder; Susan E Varni; Kimberly A Murray; Timothy B Plante; Andrea C Villanti; Daniel L Wolfson; Sanchit Maruti; Kathleen M Fairfield
Journal:  Int J Drug Policy       Date:  2021-06-06

8.  Efficiency and safety: comparison between preoperative analgesia and postoperative analgesia using non-steroidal anti-inflammatory drugs in patients receiving arthroscopic knee surgery in a multicenter, randomized, controlled study.

Authors:  Ling Ma; Liguo Zhang; Hanbing Wang; Changlin Jiang
Journal:  Inflammopharmacology       Date:  2021-04-02       Impact factor: 4.473

9.  Chronic opioid use modulates human enteric microbiota and intestinal barrier integrity.

Authors:  Angélica Cruz-Lebrón; Ramona Johnson; Claire Mazahery; Zach Troyer; Samira Joussef-Piña; Miguel E Quiñones-Mateu; Christopher M Strauch; Stanley L Hazen; Alan D Levine
Journal:  Gut Microbes       Date:  2021 Jan-Dec

Review 10.  Neurocognitive impairments and brain abnormalities resulting from opioid-related overdoses: A systematic review.

Authors:  Erin L Winstanley; James J Mahoney; Felipe Castillo; Sandra D Comer
Journal:  Drug Alcohol Depend       Date:  2021-06-24       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.